Highlights
KLSE: PHARMA (7081)       PHARMANIAGA BHD MAIN : Health Care
Last Price Today's Change   Day's Range   Trading Volume
4.93   -0.01 (0.20%)  4.90 - 4.99  363,800
Analyze this stock with MQ Trader system

Financials


Market Cap: 1,290 Million

Market Cap 1,290 Million
NOSH 262 Million

Latest Audited Result:  31-Dec-2019

Latest Audited Result: 31-Dec-2019
Announcement Date 19-Jun-2020
Next Audited Result: 31-Dec-2020
Est. Ann. Date: 19-Jun-2021
Est. Ann. Due Date: 29-Jun-2021

Latest Quarter:  30-Sep-2020 [#3]

Latest Quarter: 30-Sep-2020 [#3]
Announcement Date 19-Nov-2020
Next Quarter: 31-Dec-2020
Est. Ann. Date: 20-Feb-2021
Est. Ann. Due Date: 01-Mar-2021
QoQ | YoY   -85.55%  |    199.79%

Annual (Unaudited) ( EPS: -57.02, P/E: -8.65 )

Revenue | NP to SH 2,820,530  |  -149,219
RPS | P/RPS 1,077.75 Cent  |  0.46
EPS | P/E | EY -57.02 Cent  |  -8.65  |  -11.57%
DPS | DY | Payout % 8.47 Cent  |  1.72%  |  - %
NAPS | P/NAPS 1.29  |  3.83
YoY   -451.37%
NP Margin | ROE -5.30%  |  -44.33%
F.Y. | Ann. Date 31-Dec-2019  |  20-Feb-2020

T4Q Result ( EPS: -55.32, P/E: -8.91 )

Revenue | NP to SH 2,806,171  |  -144,778
RPS | P/RPS 1,072.26 Cent  |  0.46
EPS | P/E | EY -55.32 Cent  |  -8.91  |  -11.22%
DPS | DY | Payout % 9.98 Cent  |  2.02%  |  - %
NAPS | P/NAPS 1.32  |  3.74
QoQ | YoY   0.66%  |    -528.13%
NP Margin | ROE -5.18%  |  -41.96%
F.Y. | Ann. Date 30-Sep-2020  |  19-Nov-2020

Annualized Result ( EPS: 17.23, P/E: 28.61 )

Revenue | NP to SH 2,787,317  |  45,093
RPS | P/RPS 1,065.06 Cent  |  0.46
EPS | P/E | EY 17.23 Cent  |  28.61  |  3.50%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   -30.36%  |    15.12%
NP Margin | ROE 1.59%  |  13.07%
F.Y. | Ann. Date 30-Sep-2020  |  19-Nov-2020



Business Performance

Business Performance (By Quarter)

Trailing 4 Quarters Trailing 8 Quarters
Available Quarters 4 Quarters 8 Quarters
Continuous Quarters Of Revenue Growth 0 / 4 0.00% 0 / 8 0.00%
Total Positive Profit Years 3 / 4 75.00% 7 / 8 87.50%
Continuous Quarters Of Positive Profit 3 / 4 75.00% 3 / 8 37.50%
Continuous Quarters Of Profit Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted EPS Growth 0 / 4 0.00% 0 / 8 0.00%
Total Dividend Years 3 / 4 75.00% 6 / 8 75.00%
Continuous Quarters Of Dividend 3 / 4 75.00% 3 / 8 37.50%
Continuous Quarters Of Dividend Growth 0 / 4 0.00% 0 / 8 0.00%
Continuous Quarters Of Adjusted Dps Growth 0 / 4 0.00% 0 / 8 0.00%
Average ROE -10.86% -4.62%
Average Net Profit Margin -5.14% -1.96%

Business Performance (By Year)

Last 5 Financial Years Last 10 Financial Years
Available Years 5 Years 10 Years
Continuous Years Of Revenue Growth 3 / 5 60.00% 3 / 10 30.00%
Total Positive Profit Years 4 / 5 80.00% 9 / 10 90.00%
Continuous Years Of Positive Profit 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Profit Growth 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Adjusted EPS Growth 0 / 5 0.00% 0 / 10 0.00%
Total Dividend Years 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Dividend 5 / 5 100.00% 10 / 10 100.00%
Continuous Years Of Dividend Growth 0 / 5 0.00% 0 / 10 0.00%
Continuous Years Of Adjusted Dps Growth 0 / 5 0.00% 0 / 10 0.00%
Average ROE -0.27% 5.83%
Average Net Profit Margin 0.97% 2.13%

Key Result

Key Result

T4Q Annualized Annual (Unaudited) Last 10 FY Average Last 5 FY Average
Revenue 2,806,171 2,787,317 2,820,530 2,068,902 2,381,556
NP to SH -144,778 45,093 -149,219 37,001 15,343
Dividend 26,125 34,852 22,177 43,339 46,449
Adjusted EPS -55.32 17.23 -57.02 14.14 5.86
Adjusted DPS 9.98 13.32 8.47 16.56 17.75

NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share

All figures in '000 unless specified.

EPS & DPS's figures in Cent.


Growth

Growth (By Quarter)

LQ QoQ LQ YoY CQ YoY LQ vs Average of T4Q LQ vs Average of T8Q
Revenue -3.25% -12.84% -0.68% -10.94% -9.25%
NP to Owner -85.55% 199.79% 15.12% 103.98% 110.40%
Dividend -39.96% 0.00% 17.91% -39.97% -41.34%
Adj. EPS -85.55% 199.79% 15.12% 103.98% 110.40%
Adj. DPS -39.96% 0.00% 17.91% -39.97% -41.34%

LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year

Growth (By Year)

T4Q vs LFY T4Q vs AL5FY T4Q vs AL10FY AQR vs LFY AQR vs AL5FY AQR vs AL10FY LFY YoY LFY vs AL5FY LFY vs AL10FY
Revenue -0.51% 17.83% 35.64% -1.18% 17.04% 34.72% 18.26% 18.43% 36.33%
NP to Owner 2.98% -1,043.61% -491.28% 130.22% 193.90% 21.87% -451.37% -1,072.55% -503.28%
Dividend 17.80% -43.75% -39.72% - % - % - % -46.72% -52.25% -48.83%
Adj. EPS 2.98% -1,043.61% -491.28% 130.22% 193.90% 21.87% -451.37% -1,072.55% -503.28%
Adj. DPS 17.80% -43.75% -39.72% - % - % - % -46.72% -52.25% -48.83%

T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year

Trade this stock and win a FREE I3investor T-shirt after 5 trades. Find out more.
  2 people like this.
 
chuosyew https://news.cgtn.com/news/2021-01-13/CEO-Sinovac-COVID-19-vaccine-safe-and-efficient-X1ac7YSHcY/share_amp.html
13/01/2021 10:53 PM
kancil850 My friend in jakarta told me today sinovac jab is starting to be administered over in his city, but he is not part of as he is older, over 60 yo.
13/01/2021 10:58 PM
BennyWhittman Water is safe, try water and it's cheap.

Safe doesn't mean it's EFFECTIVE. Damn it, people's lives at stake and they still want to profit on fake meds.

The term safe means it doesn't have adverse side effect. The main criteria is to PROTECT and do it's job well, with efficacy above 90%

Those who want to have FALSE PROTECTION, please line up for this shot.
14/01/2021 8:28 AM
Goldberg Read this article: Evidence that prove JP Morgan's Jeffrey Ng analyst report on Glove is irresponsible and materially full with false data

https://klse.i3investor.com/blogs/GillianTan/2021-01-14-story-h1539323...
14/01/2021 8:42 AM
BennyWhittman Anyone who believed the tales told by Investment Bankers duly DESERVED what they get. Suffer the consequences. JP also predicted TG to go down by 50% to RM3.50. Hogwash.
14/01/2021 1:07 PM
TecStock https://newsaf.cgtn.com/news/2021-01-14/Turkish-health-minister-gets-Sinovac-vaccine-jab-X1RW4FaqhW/index.html
14/01/2021 1:36 PM
chuosyew https://www.astroawani.com/berita-dunia/turkey-approves-chinabased-sinovac-vaccines-emergency-use-277713
14/01/2021 3:17 PM
pang72 Steady lo..
Vaccine mari..

Glove kena short
14/01/2021 4:41 PM
pang72 Kita tight tight vaccine
14/01/2021 4:41 PM
eyeHunter We refer to Pharma’s announcement dated 12 January 2021 in respect of the aforesaid matter.


In this connection, kindly furnish Bursa Securities with the following additional information for public release:



1) Whether PLS possesses the required expertise, knowhow and resources to manufacture the Covid-19 vaccine.

2) The tentative timeframe to enter into the Local Manufacturing Agreement and a Technology and Know-How License Agreement with SINOVAC LS.

3) The risks in relation to the manufacturing of the Covid-19 vaccine that PLS may be exposed to.

4) To elaborate the manner in which PLS intends to market and distribute the Covid-19 vaccine and whether any contract has been secured todate.

5) To specify the relevant authorities’ approvals required for the clinical trial of the Covid-19 vaccine and the manufacturing, distribution and sale of the Covid-19 vaccine in Malaysia together with the status of approval, where applicable.

6) The estimated total capital outlay or costs to be incurred and the source of funding for the manufacturing of Covid- 19 vaccine.



Please furnish Bursa Securities with your reply within one (1) market day from the date hereof.



Yours faithfully





Listing

Regulation
14/01/2021 6:44 PM
eyeHunter Where is the reply?
14/01/2021 6:45 PM
BennyWhittman Mr President aka Joyvest (paid trooper from Bintai and Solution forum), We didn't know that Pfizer-BioNTech Pharmceutical belongs to your father. If so, kindly expedite Malaysian' procurement.

KJ has announced that MOSTI is flexible and will not proceed if any Vaccines failed it's Standard and Efficiency. NPRA also have the CTIL certified prior to any APPROVALS.
14/01/2021 7:49 PM
BennyWhittman Where did he go? Tail between his legs also can run away so fast.
14/01/2021 7:54 PM
Zolan2020 no hope la. better run to dpharma.
14/01/2021 9:27 PM
shark3011 https://www.freemalaysiatoday.com/category/nation/2021/01/14/rm5mil-fine-and-jail-if-private-hospitals-say-no-to-covid-19-patients/
14/01/2021 9:40 PM
Godofgambler Wow pharma going to manufacture sinovac
vaccine locally? Well done!!!
14/01/2021 11:39 PM
Godofgambler Pharmaniaga said it had initiated negotiation for the local manufacturing agreement as well as the technology and know-how licence agreement with Sinovac LS, which are expected to be executed within one month
14/01/2021 11:47 PM
Sales Glove stock more valuable.....
15/01/2021 12:07 PM
cloudde I'm not sure if they're going to manufacture the vaccines but from the announcement, they managed to procure ready vaccines to be used and in bulk (for the fill and finish). Bear in mind that we're in a pandemic and that many high economic activities are under MCO. My guess is that the bulk of vaccines they've procured will also be allocated and prioritized to KKM and private hospitals.

Don't see this as a race between Pharma and Duopharma as even with PFE's and Sinovac's vaccines secured, we're still short to cover the target 80% population. And each person will require 2 doses. Profitability wise, this is a good additional mid-term revenue source for PHARMA and I don't see it going away anytime soon. Even with other vaccines supply, the fill and finish approach is still the most practical to reduce overall vaccines cost to users. I highly doubt PFE or others would allow manufacturing locally and not sure if it's feasible to transport huge bulk of PFE for fill and finish (imagine to ensure huge tanks at -80 degrees - such technological challenge)

I'm not privy to Duopharma's progress in securing vaccine supplies besides this old post. Anyone has updated information? It's kinda odd since KJ was seen as leading the negotiations for both companies but only announced for PHARMA. Did Duopharma's negotiation fell apart?

https://www.theedgemarkets.com/article/duopharma-ready-package-covid19-vaccines
15/01/2021 12:19 PM
BennyWhittman MOSTI have come out in defense of their choice in Sinovac's CoronaVac. As the reports of lower than earlier expected efficacy, perhaps they may have a second look. Otherwise, NPRA might need to properly scrutinise the CTIL from other countries, especially Brazil and now Indonesia. As for R&D and transfer of technology with local manufacturing, that would be a step too soon at the moment but still on the cards.

Pfizer's vaccine requirement for the cold chain transportation has been addressed by MOSTI with the recent purchase of some 55 units of deep freeze fridges. The vaccines would be most probably shipped in vials and require dilution in saline before shooting into arms. Should not be thawed for FnF. The genetic engineering technology for this vaccine may still not be transferable give the high end equipment, facilities and meticulous procedures.

Nobody hold privy to the GLCs roles and responsibilities in rolling out the vaccines. We are all having calculated definitions of their capabilities and on-going current services rendered to MOH. Coupled with the fact that MOSTI had announced their participation in the roll-out plans.
15/01/2021 1:06 PM
BennyWhittman The reason that Pharma is getting the chinese vaccine Contract is because they are the GLC which has been performing the logistic and deliveries to all Govt hospitals, penetrating even the rural jungle villages. As mentioned before, NO MIDDLEMAN. Some naysayers still don't seem to understand the context of commerce in business transactions.

Govt is buying the vaccine and bringing in Pharma to the table. It's not that Pharma has decided to buying the vaccine and sell it to the govt.

The govt approved the procurement and hand it to Pharma to facilitate the real and actual import and downstream exercise.

The same scenario would presumably be happening to Dpharma. With Pharma's re-purposing their FnF facility and hitting full capacities, Dpharma may be awarded the AZ or Sputnik V, although AZ seems higher possibility with their approved EUA status from UK, USA, Europe and many other countries.
15/01/2021 1:17 PM
flyborn Good explanation benny
Same principle of business happen in uae, whereby government purchases such vaccines and government agencies distribute to the uae people including ex.
Hopefully Pharmaniaga will get profits for that.
15/01/2021 7:12 PM
TecStock https://www.euroweeklynews.com/2021/01/15/norway-changes-vaccine-guidelines-after-23-deaths/
16/01/2021 3:23 PM
TecStock http://enapp.globaltimes.cn/#/article/1212939
16/01/2021 3:25 PM
Lifeunlimited https://www.klsescreener.com/v2/news/view/779047
16/01/2021 4:25 PM
eYuppie Will govt continue with Sinovac after reported only 50.3% efficacy in Brazil?
How about the Chinese vaccine Sinopharm? Cambodia PM is injecting the Sinopharm vaccine.
https://www.khmertimeskh.com/50804325/pm-i-will-get-the-covid-19-vaccine-first/
17/01/2021 7:31 PM
FortuneBlooming ha ha ha
17/01/2021 10:34 PM
FortuneBlooming Something fishy: Pfizer CEO not jabbing himself with Pfizer vaccine raises big questions

https://www.news18.com/amp/news/buzz/something-fishy-pfizer-ceo-not-getting-his-own-companys-covid-19-vaccine-raises-questions-3182408.html
17/01/2021 10:34 PM
FortuneBlooming What a big joker
17/01/2021 10:35 PM
FortuneBlooming What a jerk
17/01/2021 10:35 PM
Godofgambler https://www.google.com/amp/s/news.cgtn.com/news/2021-01-17/China-s-vaccine-can-cross-neutralize-different-COVID-strains-CNBG-X7DidHHXP2/share_amp.html
17/01/2021 10:57 PM
bigby7 China Vaccine 50% effective..
Now pfizer deaths..From 23 to 29 now
Scary oh..

Tomorrow market merah..


https://www.bloomberg.com/news/articles/2021-01-16/norway-vaccine-fata...
18/01/2021 12:12 AM
eYuppie https://www.scmp.com/coronavirus/europe/article/3118087/coronavirus-norway-raises-concern-over-pfizer-jabs-elderly

Norway has expressed increasing concern about the safety of the Pfizer-BioNTech vaccine on elderly people with serious underlying health conditions after raising an estimate of the "number who died after receiving inoculations to 29".
18/01/2021 12:42 AM
Godofgambler https://www.reuters.com/article/us-health-coronavirus-brazil/brazil-clears-emergency-use-of-sinovac-astrazeneca-vaccines-shots-begin-idUSKBN29M0M3
18/01/2021 7:31 AM
Godofgambler https://www.bbc.com/news/uk-55698132
18/01/2021 7:33 AM
eYuppie https://www.khmertimeskh.com/50804460/why-were-us-media-silent-on-pfizer-vaccine-deaths/
Why were US media silent on Pfizer vaccine deaths?
18/01/2021 12:42 PM
uppvestor march start vaccination dy... time to in
18/01/2021 6:21 PM
STEADYBOMBIBI85 https://www.urdupoint.com/en/miscellaneous/serbia-approves-chinas-sinopharm-vaccine-for-1145157.html
19/01/2021 6:50 PM
STEADYBOMBIBI85 https://www.malaymail.com/news/world/2021/01/19/pakistan-approves-chinese-sinopharm-covid-19-vaccine-for-emergency-use/1941771
19/01/2021 6:50 PM
STEADYBOMBIBI85 https://english.alarabiya.net/en/coronavirus/2021/01/10/Coronavirus-Jordan-approves-China-s-Sinopharm-COVID-19-vaccine
19/01/2021 7:05 PM
STEADYBOMBIBI85 https://www.reuters.com/article/us-health-coronavirus-vaccine-sinopharm/sinopharm-covid-19-vaccine-could-be-cleared-for-use-in-minors-before-march-state-media-idUSKBN29K0SE
19/01/2021 9:04 PM
MoneyAndHoney Good Lord!
20/01/2021 7:01 AM
MoneyAndHoney Mashallah!
20/01/2021 7:01 AM
MoneyAndHoney All Malaysian states (except Sarawak) under MCO from Friday

https://www.channelnewsasia.com/news/asia/malaysia-covid-19-mco-all-states-except-sarawak-jan-22-feb-4-13993694
20/01/2021 7:01 AM
MoneyAndHoney Oh dear
20/01/2021 7:02 AM
BennyWhittman Anticipating and relishing the prospect of another USA based Covid-19 Vaccine reporting their CTIL in 2-3 weeks, which is end Jan or early Feb 2021. Another TRUSTED, reliable brand and highly respected Pharmaceutical company for generations.....J&J
20/01/2021 9:01 AM
nicholas99 run..
20/01/2021 10:21 AM
pertamina Soon mco will ended forever. No pkpb etc. Already got vaccine.
20/01/2021 10:31 PM
BennyWhittman PM assured vaccination of 27 million people with time-frame of 12 months. MOSTI just announced last week, they need a timeline of 18 months to work.....disarray of submission, approvals, supplies, roll out, all strangely GLARING in front of our eyes. Can anyone or anything be well coordinated and executed for once? For the people's sake, put more focus.

https://www.malaysiakini.com/news/559846

Even the dossier of those earmarked Vaccines under procurement has NOT EVEN been submitted to NPRA for approvals. How long more do we need to wait and stay patience for some protection?
21/01/2021 12:56 PM
questra Down down down down??
22/01/2021 12:02 AM